Lars Iversen, MD, DMSc
Aarhus University Hospital
IPC Board Member
Psoriasis. Griffiths C, Armstrong A, Gudjonsson J, Barker J. Lancet. vol. 397. no. 10281. 2021 Apr; 397: 1301–15. doi: 10.1016/s0140-6736(20)32549-6.
In the April 2021 issue of the Lancet, four of our esteemed colleagues in the IPC published an updated and comprehensive review of the current pieces of knowledge on psoriasis.
It is a very well-written review covering all aspects of psoriasis spanning from epidemiology and pathophysiology to clinical presentation, associated diseases, and the management of psoriasis. Alongside an update of the most recently published literature in the field of psoriasis, the manuscript is also accompanied by clear clinical pictures, figures that elegantly explain the pathogenesis of psoriasis, and tables that provide a good overview of the different treatment options.
The review is up-to-date and discusses the current knowledge and challenges in managing psoriasis during the SARS-CoV-2 pandemic and nicely points out future directions of psoriasis research by highlighting unresolved questions, new developments, and unmet medical needs. Because of the comprehensive nature of this manuscript, it appeals to those who want to gain an overview of the various aspects of psoriasis and those who are searching for an in-depth understanding of specific aspects of psoriasis and its subtypes such as their different pathophysiologies.
This manuscript will undoubtedly serve as a critical reference paper in the field of psoriasis in the coming years.